Literature DB >> 12944547

Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001.

T J Anderson1, C Davis, F E Alexander, H M Dobson.   

Abstract

AIMS: To examine pathology characteristics of breast cancers detected by mammography screening over 10 years in Scotland, and compare the nature of cancer yields after different levels of very small invasive cancer at prevalence detection.
METHODS: A pathology database of cancers from mammography screening of women aged 50-64 years invited every three years was used to assess the variation over time in annual yield of different invasive cancer sizes. Screening centres were compared for incidence screen yields, according to sizes, histological type, grade, and node status.
RESULTS: There was a significant trend over time for increased detection of < 15 mm cancers among 2353 prevalence cancers, and a significant trend for increase in all size groups, < 10, 10-14, < 15, and >or= 15 mm, among 2245 incidence cancers. Based on individual screening centres, there was a significant negative relation between proportions of very small (< 10 mm) cancers at prevalence screens and of large (>or= 15 mm) cancers at incidence screens of the same "cohort" three years later. There was no significant relation on the same centre basis for worse pathology characteristics (histological no special type, high grade, and positive node status) in cancers detected in the same "cohort" three years later.
CONCLUSIONS: Sensitive mammography screening has a significant effect on the nature of yields at subsequent screens. Length of screening interval and consistency in pathologist opinions are factors that account for lack of effect on incidence cancer qualitative pathology characteristics. These issues are relevant to the use of such characteristics as surrogate measures of service screening performance.

Entities:  

Mesh:

Year:  2003        PMID: 12944547      PMCID: PMC1770056          DOI: 10.1136/jcp.56.9.654

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  The natural history of breast carcinoma: what have we learned from screening?

Authors:  T J Anderson; F E Alexander; P M Forrest
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

2.  Breast cancer screening sensitivity in the NHSBSP: recent results and implications.

Authors:  R G Blanks; S M Moss
Journal:  Breast       Date:  1999-12       Impact factor: 4.380

3.  Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate.

Authors:  R G Blanks; N E Day; S M Moss
Journal:  J Med Screen       Date:  1996       Impact factor: 2.136

4.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways.

Authors:  Rebecca Roylance; Patricia Gorman; Andrew Hanby; Ian Tomlinson
Journal:  J Pathol       Date:  2002-01       Impact factor: 7.996

6.  Does breast cancer grade worsen with time? Evidence from breast screening.

Authors:  A Johnson; J Shekhdar
Journal:  Breast Cancer Res Treat       Date:  2001-08       Impact factor: 4.872

7.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

8.  The natural history of breast carcinoma: what have we learned from screening?

Authors:  L Tabár; S W Duffy; B Vitak; H H Chen; T C Prevost
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

9.  Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

Authors:  J P Sloane; R Ellman; T J Anderson; C L Brown; J Coyne; N S Dallimore; J D Davies; D Eakins; I O Ellis; C W Elston
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Breast cancer screening programmes: the development of a monitoring and evaluation system.

Authors:  N E Day; D R Williams; K T Khaw
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  2 in total

1.  Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Authors:  Stephen W Duffy; Amanda Dibden; Dimitrios Michalopoulos; Judith Offman; Dharmishta Parmar; Jacquie Jenkins; Beverley Collins; Tony Robson; Suzanne Scorfield; Kathryn Green; Clare Hall; Xiao-Hui Liao; Michael Ryan; Fiona Johnson; Guy Stevens; Olive Kearins; Sarah Sellars; Julietta Patnick
Journal:  Lancet Oncol       Date:  2015-12-05       Impact factor: 41.316

2.  Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation.

Authors:  Manmeet Kaur; Kanwardeep Kaur Tiwana; Nisha Singla
Journal:  Niger J Surg       Date:  2019 Jan-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.